reviewNature Reviews Drug DiscoveryApr 27, 2007Closed access

The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept

Drexel University · Monmouth Medical Center · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

878
total citations
FWCI
26.08
Percentile
100%
References
190
Citations per year

Authors

4

Topics & keywords

Keywords
  • TRPV1
  • Medicine
  • Transient receptor potential channel
  • Chronic pain
  • Migraine
  • Pharmacology
  • Internal medicine
  • Receptor
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.